GAP-JAPAN
Letter of Intent
Describes the intent to establish a Global Alliance for Pharmacogenomics between U.S. and Japanese scientists who conduct research in the fields of genetics, pharmacology, medicine, and pharmacogenetics/pharmacogenomics.
Acknowledgements
Contributions of the groups that made the studies possible.
Launching a Global Alliance for Pharmacogenomics
April 14, 2008 • National Institute of General Medical Sciences
U.S. and Japanese scientists partner to study genetic factors that influence the safety and effectiveness of medicines.
First set of studies for the GAP-JAPAN
Global Alliance for Pharmacogenomics Expands
November 10, 2008 • National Institute of General Medical Sciences
Five New Collaborative Projects Will Advance Understanding of Genetic Factors that Influence the Safety and Effectiveness of Medicines.
Second set of studies for the GAP-JAPAN
GAP-JAPAN Investigators, San Francisco 2009
GAP-JAPAN Investigators, Yokohama 2008
